• 22-MAR-2012

  • SOURCE: IBM

Memorial Sloan-Kettering Cancer Center, IBM to Collaborate in Applying Watson Technology to Help Oncologists

IBM Watson combined with MSKCC's clinical knowledge will help physicians access and integrate latest science and knowledge

Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM (NYSE: IBM) have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. The resulting decision support tool will help doctors everywhere create individualized cancer diagnostic and treatment and recommendations for their patients based on current evidence.